BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region

Autor: Wozniak, K., Piaskowski, S., Gresner, S.M., Golanska, E., Bieniek, E., Bigoszewska, K., Sikorska, B., Szybka, M., Kulczycka-Wojdala, D., Zakrzewska, M., Zawlik, I., Papierz, W., Stawski, R., Jaskolski, D.J., Och, W., Sieruta, M., Liberski, P.P., Rieske, P.

Publikováno v: In Cancer Genetics and Cytogenetics 2008 183(1):14-20

A Systematic Review of Sporadic Creutzfeldt-Jakob Disease: Pathogenesis, Diagnosis, and Therapeutic Attempts.

Autor: Jurcau, Maria Carolina¹ (AUTHOR) mariacarolina.jurcau@student.uoradea.ro, Jurcau, Anamaria² (AUTHOR) anamaria.jurcau@gmail.com, Diaconu, Razvan Gabriel¹ (AUTHOR), Hogea, Vlad Octavian¹ (AUTHOR), Nunkoo, Vharoon Sharma³ (AUTHOR)

Publikováno v: Neurology International. Oct2024, Vol. 16 Issue 5, p1039-1065. 27p.

Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study.

Autor: Jones E; Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK., Hummerich H; Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK., Viré E; Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK., Uphill J; Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK., Dimitriadis A; Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK., Speedy H; Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK., Campbell T; Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK., Norsworthy P; Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK., Quinn L; Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK., Whitfield J; Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK., Linehan J; Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK., Jaunmuktane Z; Division of Neuropathology, University College London Hospitals National Health Service Foundation Trust, London, UK; Department of Clinical and Movement Neurosciences and Queen Square Brain Bank for Neurological Disorders, University College London Queen Square Institute of Neurology, London, UK., Brandner S; Division of Neuropathology, University College London Hospitals National Health Service Foundation Trust, London, UK; Department of Neurodegenerative Disease, University College London Queen Square Institute of Neurology, London, UK., Jat P; Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK., Nihat A; Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK; National Prion Clinic, University College London Hospitals National Health Service Foundation Trust, London, UK., How Mok T; Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK; National Prion Clinic, University College London Hospitals National Health Service Foundation Trust, London, UK., Ahmed P; Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK., Collins S; Australian National Creutzfeldt-Jakob Disease Registry, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC, Australia., Stehmann C; Australian National Creutzfeldt-Jakob Disease Registry, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC, Australia., Sarros S; Australian National Creutzfeldt-Jakob Disease Registry, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC, Australia., Kovacs GG; Institute of Neurology, Medical University of Vienna, Vienna, Austria; Department of Laboratory Medicine and Pathobiology and Tanz Centre for Research in Neurodegenerative Disease, University of Toronto, Toronto, ON, Canada; Laboratory Medicine Program, Krembil Brain Institute, University Health Network, Toronto, ON, Canada., Geschwind MD; University of California San Francisco Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA, USA., Golubjatnikov A; University of California San Francisco Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA, USA., Frontzek K; Institute of Neuropathology, University of Zurich, Zurich, Switzerland., Budka H; Institute of Neuropathology, University of Zurich, Zurich, Switzerland; Medical University Vienna, Vienna, Austria., Aguzzi A; Institute of Neuropathology, University of Zurich, Zurich, Switzerland., Karamujić-Čomić H; Department of Epidemiology, Erasmus Medical Centre, Rotterdam, Netherlands., van der Lee SJ; Department of Epidemiology, Erasmus Medical Centre, Rotterdam, Netherlands., Ibrahim-Verbaas CA; Department of Epidemiology, Erasmus Medical Centre, Rotterdam, Netherlands., van Duijn CM; Department of Epidemiology, Erasmus Medical Centre, Rotterdam, Netherlands; Nuffield Department of Population Health, University of Oxford, Oxford, UK., Sikorska B; Department of Molecular Pathology and Neuropathology, Medical University of Lodz, Lodz, Poland., Golanska E; Department of Molecular Pathology and Neuropathology, Medical University of Lodz, Lodz, Poland., Liberski PP; Department of Molecular Pathology and Neuropathology, Medical University of Lodz, Lodz, Poland., Calero M; Chronic Disease Programme (UFIEC-CROSADIS) and Network Centre for Biomedical Research in Neurodegenerative Diseases (CIBERNED), and Alzheimer Disease Research Unit, CIEN Foundation, Queen Sofia Foundation Alzheimer Centre, Instituto de Salud Carlos III, Madrid, Spain., Calero O; Chronic Disease Programme (UFIEC-CROSADIS) and Network Centre for Biomedical Research in Neurodegenerative Diseases (CIBERNED), and Alzheimer Disease Research Unit, CIEN Foundation, Queen Sofia Foundation Alzheimer Centre, Instituto de Salud Carlos III, Madrid, Spain., Sanchez-Juan P; Neurology Service, University Hospital Marqués de Valdecilla, University of Cantabria, CIBERNED and IDIVAL, Santander, Spain., Salas A; Unidade de Xenética, Instituto de Ciencias Forenses (INCIFOR), Facultade de Medicina, Universidade de Santiago de Compostela, and GenPoB Research Group, Instituto de Investigaciones Sanitarias (IDIS), Hospital Clínico Universitario de Santiago (SERGAS), Galicia, Spain., Martinón-Torres F; Translational Paediatrics and Infectious Diseases, Department of Paediatrics, Hospital Clínico Universitario de Santiago de Compostela, Galicia, Spain., Bouaziz-Amar E; Department of Biochemistry and Molecular Biology, Lariboisière Hospital, AP-HP, University of Paris, Paris, France., Haïk S; Sorbonne Université, INSERM U1127, CNRS UMR 7225, Institut du Cerveau et de la Moelle épinière, Paris, France; Cellule nationale de référence des maladies de Creutzfeldt-Jakob, AP-HP, University Hospital Pitié-Salpêtrière, Paris, France., Laplanche JL; Department of Biochemistry and Molecular Biology, Lariboisière Hospital, AP-HP, University of Paris, Paris, France., Brandel JP; Sorbonne Université, INSERM U1127, CNRS UMR 7225, Institut du Cerveau et de la Moelle épinière, Paris, France; Cellule nationale de référence des maladies de Creutzfeldt-Jakob, AP-HP, University Hospital Pitié-Salpêtrière, Paris, France., Amouyel P; INSERM, CHU Lille, Institut Pasteur de Lille, U1167-RID-AGE, Labex DISTALZ, University of Lille, Lille, France., Lambert JC; INSERM, CHU Lille, Institut Pasteur de Lille, U1167-RID-AGE, Labex DISTALZ, University of Lille, Lille, France., Parchi P; IRCCS, Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy; Department of Experimental, Diagnostic, and Specialty Medicine, University of Bologna, Bologna, Italy., Bartoletti-Stella A; IRCCS, Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy., Capellari S; IRCCS, Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy; Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy., Poleggi A; Department of Neuroscience, Istituto Superiore di Sanità, Rome, Italy., Ladogana A; Department of Neuroscience, Istituto Superiore di Sanità, Rome, Italy., Pocchiari M; Department of Neuroscience, Istituto Superiore di Sanità, Rome, Italy., Aneli S; Department of Medical Sciences, Università degli studi di Torino, Torino, Italy., Matullo G; Department of Medical Sciences, Università degli studi di Torino, Torino, Italy., Knight R; National Creutzfeldt-Jakob Disease Research and Surveillance Unit, Edinburgh, UK., Zafar S; Department of Neurology, Clinical Dementia Centre and National Reference Centre for Creutzfeldt-Jakob Disease Surveillance, University Medical School, Göttingen, Germany; German Centre for Neurodegenerative Diseases (DZNE), Göttingen, Germany; Biomedical Engineering and Sciences Department, School of Mechanical and Manufacturing Engineering, National University of Sciences and Technology, Islamabad, Pakistan., Zerr I; Department of Neurology, Clinical Dementia Centre and National Reference Centre for Creutzfeldt-Jakob Disease Surveillance, University Medical School, Göttingen, Germany; German Centre for Neurodegenerative Diseases (DZNE), Göttingen, Germany., Booth S; Prion Disease Program, Public Health Agency of Canada, Winnipeg, MB, Canada., Coulthart MB; Canadian Creutzfeldt-Jakob Disease Surveillance System, Public Health Agency of Canada, Ottawa, ON, Canada., Jansen GH; Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, ON, Canada., Glisic K; Departments of Pathology and Neurology, Case Western Reserve University, Cleveland, OH, USA; National Prion Disease Pathology Surveillance Center, Case Western Reserve University, Cleveland, OH, USA., Blevins J; Departments of Pathology and Neurology, Case Western Reserve University, Cleveland, OH, USA; National Prion Disease Pathology Surveillance Center, Case Western Reserve University, Cleveland, OH, USA., Gambetti P; Departments of Pathology and Neurology, Case Western Reserve University, Cleveland, OH, USA; National Prion Disease Pathology Surveillance Center, Case Western Reserve University, Cleveland, OH, USA., Safar J; Departments of Pathology and Neurology, Case Western Reserve University, Cleveland, OH, USA; National Prion Disease Pathology Surveillance Center, Case Western Reserve University, Cleveland, OH, USA., Appleby B; Departments of Pathology and Neurology, Case Western Reserve University, Cleveland, OH, USA; National Prion Disease Pathology Surveillance Center, Case Western Reserve University, Cleveland, OH, USA., Collinge J; Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK; National Prion Clinic, University College London Hospitals National Health Service Foundation Trust, London, UK., Mead S; Medical Research Council Prion Unit, University College London Institute of Prion Diseases, London, UK; National Prion Clinic, University College London Hospitals National Health Service Foundation Trust, London, UK. Electronic address: s.mead@prion.ucl.ac.uk.

Publikováno v: The Lancet. Neurology [Lancet Neurol] 2020 Oct; Vol. 19 (10), pp. 840-848. Date of Electronic Publication: 2020 Sep 16.

Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases.

Autor: Zerr I; Department of Neurology, University Medical School, Göttingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany., Schmitz M; Department of Neurology, University Medical School, Göttingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany., Karch A; Department of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany., Villar-Piqué A; Department of Neurology, University Medical School, Göttingen, Germany., Kanata E; Laboratory of Pharmacology, School of Health Sciences, Department of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, Greece., Golanska E; Department of Molecular Pathology and Neuropathology, Medical University of Lodz, Lodz, Poland., Díaz-Lucena D; Network Center for Biomedical Research in Neurodegenerative Diseases, (CIBERNED), Institute Carlos III, Ministry of Health, Hospitalet de Llobregat, Barcelona, Spain., Karsanidou A; Laboratory of Pharmacology, School of Health Sciences, Department of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, Greece., Hermann P; Department of Neurology, University Medical School, Göttingen, Germany., Knipper T; Department of Neurology, University Medical School, Göttingen, Germany., Goebel S; Department of Neurology, University Medical School, Göttingen, Germany., Varges D; Department of Neurology, University Medical School, Göttingen, Germany., Sklaviadis T; Laboratory of Pharmacology, School of Health Sciences, Department of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, Greece., Sikorska B; Department of Molecular Pathology and Neuropathology, Medical University of Lodz, Lodz, Poland., Liberski PP; Department of Molecular Pathology and Neuropathology, Medical University of Lodz, Lodz, Poland., Santana I; Neurology Department, CHUC-Centro Hospitalar e Universitário de Coimbra, CNC- Center for Neuroscience and Cell Biology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal., Ferrer I; Network Center for Biomedical Research in Neurodegenerative Diseases, (CIBERNED), Institute Carlos III, Ministry of Health, Hospitalet de Llobregat, Barcelona, Spain; Senior Consultant, Bellvitge University Hospital-IDIBELL, Department of Pathology and Experimental Therapeutics, University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain., Zetterberg H; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK; UK Dementia Research Institute, London, UK., Blennow K; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden., Calero O; Network Center for Biomedical Research in Neurodegenerative Diseases, (CIBERNED), Institute Carlos III, Ministry of Health, Hospitalet de Llobregat, Barcelona, Spain; Alzheimer Disease Research Unit, CIEN Foundation; Queen Sofia Foundation Alzheimer Center; Chronic Disease Programme Carlos III Institute of Health, Madrid, Spain., Calero M; Network Center for Biomedical Research in Neurodegenerative Diseases, (CIBERNED), Institute Carlos III, Ministry of Health, Hospitalet de Llobregat, Barcelona, Spain; Alzheimer Disease Research Unit, CIEN Foundation; Queen Sofia Foundation Alzheimer Center; Chronic Disease Programme Carlos III Institute of Health, Madrid, Spain., Ladogana A; Department of Neurosciences, Istituto Superiore di Sanità, Rome, Italy., Sánchez-Valle R; Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Department, Hospital Clínic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Baldeiras I; Neurology Department, CHUC-Centro Hospitalar e Universitário de Coimbra, CNC- Center for Neuroscience and Cell Biology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal., Llorens F; Network Center for Biomedical Research in Neurodegenerative Diseases, (CIBERNED), Institute Carlos III, Ministry of Health, Hospitalet de Llobregat, Barcelona, Spain. Electronic address: franc.llorens@gmail.com.

Publikováno v: Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2018 Jun; Vol. 14 (6), pp. 751-763. Date of Electronic Publication: 2018 Feb 03.

Cerebrospinal Fluid Biomarker-Based Diagnosis of Sporadic Creutzfeldt-Jakob Disease: A Validation Study for Previously Established Cutoffs.

Autor: Llorens F; Department of Neurology, University Medical Center Göttingen, and German Center for Neurodegenerative Diseases (DZNE)-site Göttingen, Göttingen, Germany., Karch A, Golanska E, Schmitz M, Lange P, Sikorska B, Liberski PP, Zerr I

Publikováno v: Dementia and geriatric cognitive disorders [Dement Geriatr Cogn Disord] 2017; Vol. 43 (1-2), pp. 71-80. Date of Electronic Publication: 2017 Jan 06.